Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Find out which rewards program is best suited for your lifestyle and spending habits. Maximize your value with our expert insights!
22,671 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
SWIFT is moving its blockchain-based cross-border settlement from pilot to production-scale, with a mid-2026 MVP and ...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
Poet Technologies has seen its stock retreat after a fast run-up. This guide breaks down why poet technologies stock ...
Starbucks shows a credible turnaround with rising traffic and profits, while Chipotle contends with growth fatigue an...
A rural moment in Tennessee becomes a masterclass in branding and financial strategy. This article explores the surpr...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...